Trending Now
VBI Vaccines Inc, (NASDAQ:VBIV) Announces the Selection of VBI-2901 and VBI-2902...
VBI Vaccines Inc, (NASDAQ:VBIV) has been a key player in the development activities of immuno-oncology vaccines and infectious diseases. Given that SARS-CoV-2 is also...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Granted Orphan Drug Designation For...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has announced that the FDA has granted TNX-2900 an Orphan Drug Designation for Prader-Willi syndrome treatment.
Tonix receives Orphan...
MAKE IT MODERN
LATEST REVIEWS
NextCure Inc (NASDAQ:NXTC) Releases Interim Data From Its Phase 1/2 Monotherapy...
NextCure Inc (NASDAQ:NXTC) recently released interim findings from its phase 1/2 Monothapy clinical study evaluating NC318.
The company revealed that it has decided not to...
MAKE IT MODERN
PERFORMANCE TRAINING
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) To Commence Construction of New Advanced Development...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) plans to hold a groundbreaking ceremony at its planned 45,000 sq. ft. clinical scale manufacturing plant in the...
Precision Biosciences Inc. (NASDAQ: DTIL) Enters Exclusive Licensing Agreement For Tiziana Life Sciences Plc’s...
Precision Biosciences Inc. (NASDAQ: DTIL) has announced an exclusive licensing agreement with Tiziana Life Sciences Plc. (NASDAQ: TLSA) for Tiziana's anti-CD£ antibody, foralumab as...
Calithera Biosciences Inc. (NASDAQ: CALA) Enters Agreement To Acquire Two Oncology Compounds from Takeda
Calithera Biosciences Inc. (NASDAQ: CALA) has entered an agreement with Takeda Pharmaceuticals Company Limited to buy two clinical-stage compounds that have shown single-agent activity...
Freeline Therapeutics Holdings (NASDAQ: FRLN) Updates Plans For Clinical Development of FLT190
Freeline Therapeutics Holdings (NASDAQ: FRLN) has updated its FLT190 timelines and plans for clinical development. The therapy treats Fabry’s disease. Fairy is a genetic...
Eros Stx Global Corp (NYSE: ESGC) Files a Form 12b-25 to Get SEC to...
Eros Stx Global Corp (NYSE: ESGC) hopes to receive a 15-day extension for filing its Annual Report. It is why it decided...
MAKE IT MODERN
